Updates are available Correction dated 2024-09-28

Article History

Received: 30 April 2024

Accepted: 7 June 2024

First Online: 27 June 2024

Change Date: 28 September 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s13555-024-01271-4

Declarations

:

: Bernhard Korge was an advisor to, and/or received speakers’ honoraria from, and/or received grants from, and/or participated in clinical trials from Abbvie, Almirall Hermal, Amgen, Beiersdorf Dermo Medical, Biogen, Bristol Myers Sqibb, Celgene, Dr. Pfleger, Galderma, Janssen-Cilag, Leo Pharma, Lilly, Novartis, Pierre Fabre, UCB Pharma. Charles W Lynde received speaker fees and/or research grants from and/or participated in advisory boards of Abbvie, Amgen, Biogen, Eli Lilly, Janssen, Novartis, Sanofi Genzyme UCB Pharma. Alena Machovcova participated in clinical trials and/or received honoraria as an investigator from, and/or participated in advisory boards, and/or received speaker fees from AbbVie, Almirall, Amgen, Janssen, LEO Pharma, Lilly, Novartis, Pfizer, Sanofi Genzyme and UCB Pharma. Elisavet Lazaridou received speaker fees and research grants from and/or participated in advisory boards from UCB Pharma. David Vidal Sarro participated in clinical trials and/or received honoraria as a consultant and/or investigator, and/or received speaker fees from AbbVie, Almirall, Janssen, Lilly, Novartis and UCB Pharma. Ines D Pousa, Frederik Fierens, Paulette Williams, Saori Shimizu, and Tanja Heidbred are employees of UCB Pharma. Richard B Warren received consulting fees from AbbVie, Almirall, Amgen, Arena, Astellas, Avillion, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, GSK, Janssen, LEO Pharma, Novartis, Pfizer, Sanofi, and UCB Pharma; research grants to his institution from AbbVie, Almirall, Janssen, LEO Pharma, Novartis, and UCB Pharma; and honoraria from Astellas, DiCE, GSK, and Union. Richard B Warren is an Editor-in-Chief of<i> Dermatology and Therapy</i>. Richard Warren was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Olivier Vanhooteghem, Marc Perrussel, and Claudio Marasca report no conflicts of interest in this work.

: CIMREAL was conducted in accordance with the International Conference on Harmonisation Good Clinical Practice (ICH-GCP) guidelines and with the Helsinki Declaration of 1975, as revised in 1983. Approval to conduct this study was obtained from the respective ethics committees of all participating centers. The patients in this manuscript have given written informed consent to the publication of their case details.